Maze Therapeutics Financial Statements 2022-2025 | MAZE

Fifteen years of historical annual and quarterly income statements for Maze Therapeutics (MAZE).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM202420232022
$0.00$168$0$0
$0.00$0$0$0
$0.00$168$0$0
$49.46$83.50$73.95$88.19
$13.96$26.42$24.61$22.83
$0.00$0$0$0
$0.00$0$0$0
$-63.42$57.59$-98.55$-111.03
$-1.87$-4.18$-1.86$-3.91
$-65.28$53.40$-100.42$-114.94
$0.00$1.17$0$0
$-65.28$52.23$-100.42$-114.94
$0.00$0$0$0
$-109.83$52.23$-100.42$-114.94
$0.00$0$0$0
$-109.83$3.41$-100.42$-114.94
$-61.78$60.88$-94.46$-107.21
$-63.42$57.59$-98.55$-111.03
$-33.38$1.42$-43.89$-57.21
$-33.38$1.25$-43.89$-57.21

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2025-03-312024-12-312024-03-312023-12-312022-12-31
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$27.58$0$21.88$0$0
$7.82$0$6.14$0$0
$0$0$0$0$0
$0$0$0$0$0
$-35.40$0$-28.01$0$0
$2.62$0$-4.48$0$0
$-32.79$0$-32.49$0$0
$0$0$0$0$0
$-32.79$0$-32.49$0$0
$0$0$0$0$0
$-32.79$-44.55$-32.49$0$0
$0$0.00$0$0$0
$-32.79$-44.55$-32.49$0$0
$-34.72$0$-27.06$0$0
$-35.40$0$-28.01$0$0
$-1.15$-18.32$-13.91$0$0
$-1.15$-18.32$-13.91$0.00$0.00